Breast Implant PMA Timeframes Tested By Inamed “Not-Approvable” Letter
This article was originally published in The Gray Sheet
Executive Summary
Firms seeking premarket approval for silicone breast implants should conduct tests designed to more closely predict rupture and gel bleed under real-world conditions, according to new FDA draft guidelines